Mixtures of computational and experimental studies have given insight into characteristics of PPARs, particularly PPAR-gamma (PPARγ) and its modulators, as well as the role of these proteins in treating type 2 diabetes (T2D), gastrointestinal diseases, and genetic disorders associated with glucose homeostasis and lipid uptake. This evidence concerns the gene PPARG and type 2 diabetes mellitus.